Filings & corporate actions
77 results filed
CSVNext results · Q2 FY27
Expected 30 Oct 2026 – 10 Nov 2026
Estimate: filed 30–41 days after quarter end, last 5 times
Dividend
₹4.00 per share · last 18 Sept 2026
2026
- 18 SeptdividendDividend · ₹4.00 per share-0.2%
- 6 AugresultsResults · Q1 FY27 · standalone+5.2%NSE
- 15 JulshareholdingShareholding · 30 Jun 2026+0.8%NSE
- 12 MayresultsResults · Q4 FY26 · standalone-5.2%NSE
- 8 AprshareholdingShareholding · 31 Mar 2026+2.8%NSE
- 3 FebresultsResults · Q3 FY26 · standalone-1.7%NSE
- 13 JanshareholdingShareholding · 31 Dec 2025-1.2%NSE
Reaction to results · all yearsrose on day 0 in 36 of 77 CSV
| Quarter | Filed | Day 0 | +5D | +20D | Rel vol |
|---|---|---|---|---|---|
| Q1 FY27 | 6 Aug 2026 | +5.2% | +3.2% | -3.4% | 65.3× |
| Q4 FY26 | 12 May 2026 | -5.2% | -13.5% | -9.4% | 1.2× |
| Q3 FY26 | 3 Feb 2026 | -1.7% | +8.0% | +0.9% | 1.8× |
| Q2 FY26 | 1 Nov 2025 | -5.2% | -9.1% | -17.6% | 1.3× |
| Q1 FY26 | 6 Aug 2025 | +3.8% | +2.6% | +7.2% | 10.5× |
| Q4 FY25 | 16 May 2025 | -1.9% | -0.9% | -6.8% | 2.6× |
| Q3 FY25 | 3 Feb 2025 | -2.1% | -5.9% | -26.2% | 2.1× |
| Q2 FY25 | 30 Oct 2024 | -6.1% | +6.6% | +9.0% | 1.8× |
| Q1 FY25 | 5 Aug 2024 | +19.8% | +21.9% | +73.7% | 16.0× |
| Q4 FY24 | 17 May 2024 | -0.6% | -8.5% | -2.8% | 0.2× |
| Q3 FY24 | 6 Feb 2024 | +1.2% | +1.7% | -7.1% | 1.8× |
| Q2 FY24 | 3 Nov 2023 | +5.0% | +18.6% | +17.7% | 2.8× |
| Q1 FY24 | 4 Aug 2023 | +5.0% | +16.6% | +27.1% | 0.5× |
| Q4 FY23 | 23 May 2023 | +0.6% | +5.8% | +11.3% | 1.9× |
| Q3 FY23 | 8 Feb 2023 | +1.9% | +0.7% | -0.4% | 0.6× |
| Q2 FY23 | 5 Nov 2022 | +12.4% | +21.1% | +14.7% | 20.2× |
| Q1 FY23 | 9 Aug 2022 | +3.4% | +6.8% | +15.8% | 3.4× |
| Q4 FY22 | 23 May 2022 | +2.4% | +2.6% | -10.4% | 1.3× |
| Q3 FY22 | 9 Feb 2022 | +0.7% | -5.2% | -15.7% | 0.5× |
| Q2 FY22 | 10 Nov 2021 | +2.2% | +5.1% | +2.7% | 4.9× |
| Q1 FY22 | 10 Aug 2021 | +0.3% | +2.1% | -1.1% | 3.0× |
| Q4 FY21 | 10 Jun 2021 | -3.2% | -9.2% | -16.6% | 1.0× |
| Q3 FY21 | 9 Feb 2021 | -2.0% | -1.9% | -0.7% | 0.6× |
| Q2 FY21 | 11 Nov 2020 | 0.0% | +4.8% | +25.5% | 1.1× |
| Q1 FY21 | 25 Aug 2020 | -7.4% | -13.5% | -18.9% | 1.2× |
| Q4 FY20 | 23 May 2020 | -2.4% | +11.7% | +65.7% | 0.6× |
| Q3 FY20 | 4 Feb 2020 | +3.9% | -1.1% | -10.4% | 0.5× |
| Q2 FY20 | 5 Nov 2019 | -2.1% | -1.4% | -5.5% | 11.9× |
| Q1 FY20 | 26 Jul 2019 | +4.7% | 0.0% | +1.9% | 3.4× |
| Q4 FY19 | 24 May 2019 | +2.2% | +1.9% | -4.1% | 3.2× |
| Q3 FY19 | 1 Feb 2019 | -2.8% | -3.9% | +1.6% | 0.9× |
| Q2 FY19 | 21 Nov 2018 | -0.4% | -1.5% | -3.0% | 0.4× |
| Q1 FY19 | 3 Aug 2018 | +1.1% | +0.8% | +8.6% | 0.9× |
| Q4 FY18 | 8 Jun 2018 | +0.3% | +1.4% | -2.8% | 0.7× |
| Q3 FY18 | 28 Feb 2018 | -1.4% | -5.9% | -6.8% | 0.6× |
| Q2 FY18 | 22 Nov 2017 | +0.7% | +2.6% | +3.9% | 0.6× |
| Q1 FY18 | 1 Aug 2017 | -0.4% | -5.1% | -4.8% | 1.6× |
| Q4 FY17 | 31 May 2017 | +2.2% | +4.3% | -0.7% | 0.8× |
| Q3 FY17 | 31 Jan 2017 | +0.2% | +2.1% | -1.4% | 2.1× |
| Q2 FY17 | 24 Nov 2016 | -1.5% | -0.6% | -1.3% | 0.4× |
| Q1 FY17 | 3 Oct 2016 | +0.2% | +4.6% | +15.3% | 0.9× |
| Q4 FY16 | 26 May 2016 | -0.2% | -0.2% | -2.0% | 0.6× |
| Q3 FY16 | 15 Feb 2016 | -2.9% | -1.7% | -3.5% | 0.5× |
| Q2 FY16 | 4 Nov 2015 | -1.4% | -3.3% | +9.0% | 0.4× |
| Q1 FY16 | 8 Aug 2015 | -5.5% | -8.3% | -18.0% | 0.8× |
| Q4 FY15 | 29 May 2015 | +0.6% | -5.4% | -3.1% | 0.3× |
| Q3 FY15 | 30 Jan 2015 | +0.1% | -10.4% | -7.3% | 0.1× |
| Q2 FY15 | 12 Nov 2014 | -2.0% | -2.5% | +8.8% | 1.2× |
| Q1 FY15 | 30 Jul 2014 | -1.2% | -1.2% | +7.4% | 0.5× |
| Q4 FY14 | 26 May 2014 | -7.6% | -5.7% | +2.6% | 3.3× |
| Q3 FY14 | 30 Jan 2014 | -1.6% | -1.3% | +1.0% | 0.7× |
| Q2 FY14 | 15 Nov 2013 | -2.8% | -1.5% | -4.8% | 0.8× |
| Q1 FY14 | 1 Aug 2013 | +0.2% | -0.2% | -0.6% | 0.5× |
| Q4 FY13 | 17 May 2013 | +8.0% | -1.4% | -6.7% | 11.2× |
| Q3 FY13 | 22 Feb 2013 | -1.1% | -3.4% | -7.3% | 5.5× |
| Q2 FY13 | 2 Nov 2012 | +1.9% | +9.5% | +12.5% | 0.7× |
| Q1 FY13 | 2 Aug 2012 | +1.9% | +1.9% | +3.6% | 2.4× |
| Q3 FY12 | 15 Feb 2012 | -3.1% | -5.5% | -4.6% | 1.4× |
| Q2 FY12 | 14 Nov 2011 | -0.1% | -5.1% | 0.0% | 0.4× |
| Q1 FY12 | 1 Aug 2011 | +0.7% | -5.3% | -5.3% | 0.2× |
| Q4 FY11 | 12 May 2011 | +0.3% | -3.2% | +1.4% | 0.9× |
| Q3 FY11 | 9 Feb 2011 | -6.8% | +1.7% | -1.3% | 3.9× |
| Q2 FY11 | 3 Nov 2010 | -1.0% | +2.0% | -8.3% | 0.7× |
| Q1 FY11 | 28 Jul 2010 | -0.8% | -1.3% | +0.3% | 1.5× |
| Q4 FY10 | 27 Apr 2010 | -2.2% | -4.9% | -14.3% | 0.8× |
| Q3 FY10 | 23 Jan 2010 | -1.3% | -1.9% | -9.2% | 0.3× |
| Q2 FY10 | 21 Oct 2009 | +3.5% | -2.6% | +5.2% | 6.1× |
| Q1 FY10 | 28 Jul 2009 | +1.1% | -0.7% | +8.7% | 4.0× |
| Q4 FY09 | 30 Apr 2009 | +2.3% | +7.7% | +25.8% | 0.5× |
| Q3 FY09 | 23 Jan 2009 | +0.6% | 0.0% | +1.5% | 2.7× |
| Q2 FY09 | 22 Oct 2008 | -1.4% | -0.7% | +14.9% | 0.3× |
| Q1 FY09 | 29 Jul 2008 | -0.2% | +11.9% | +8.8% | 0.6× |
| Q4 FY08 | 9 Jun 2008 | -0.2% | +3.4% | -7.5% | 0.7× |
| Q3 FY08 | 29 Jan 2008 | -4.3% | -6.2% | -10.7% | 0.3× |
| Q2 FY08 | 12 Oct 2007 | -1.9% | -7.6% | -11.4% | 0.4× |
| Q1 FY08 | 26 Jul 2007 | -2.4% | -4.8% | +0.3% | 0.8× |
| Q4 FY07 | 30 May 2007 | +5.2% | +3.5% | +0.8% | 7.2× |
| Average | +0.1% | +0.2% | +1.4% | ||
Close-to-close from the session before the filing could trade. Day 0 is the first session after it.
Growth · Q1 FY27
CSVRevenue YoY+11.3%
Profit YoY+8.5%
Interest cost YoY-1.8%
Revenue QoQ+11.3%
Profit QoQ+33.9%
| CAGR | 2Y | 3Y | 4Y | 5Y | 6Y | 7Y |
|---|---|---|---|---|---|---|
| Revenue | +8.8% | +10.1% | +12.6% | +16.1% | +13.3% | +9.6% |
| Profit | +16.6% | +25.0% | +31.2% | +34.3% | +63.3% | +29.7% |
Key data
CSVOpen334.00
Day range327.35 – 336.55
52-week range327.35 – 640.85
From 52w high-47.7%
RSI (14)32.2
ATR (14)10.76
Volume2.10L
Avg volume (20D)2.24L
Rel volume0.94×
Volatility (1Y)42.0%
Turnover₹7.0Cr
SMA 50 / 200363.86 / 391.29
Delivery percentage
Latest · 6 Oct 202655.9%
20-day avg59.4%
1-year avg53.6%
Percentile (own history)50th
Range10.6–100.0%
Sessions1,731
Over the last 20 sessions INDRAMEDCO settled 59.4% of its traded quantity, which is above average for an NSE equity. Its one-year average is 53.6%, so recent sessions are running 5.8 points higher than usual. The latest session ranks higher than 50% of the 1,731 sessions on record for it.
What delivery percentage measuresScan the whole market on delivery
IndustryHospital
Performance returns
CSV| 1D | 1W | 1M | 3M | 6M | 1Y | |
|---|---|---|---|---|---|---|
| Price | +0.36% | -6.90% | -5.95% | -11.53% | -16.13% | -25.00% |
Valuation
CSVMarket cap₹3,072 Cr
P/E (TTM)16.3
EPS (TTM)20.51
Shares outstanding9.17Cr
Listed17 Apr 1997
Ownership
CSVPromoter51.00%
Promoter Δ QoQ0.00 pp
Public49.00%
FII2.77%
DII0.59%
Pledged0.00%
Quarterly results · standalone
CSV| Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|
| Revenue (₹ Cr) | 381.0 | 371.6 | 364.8 | 406.2 |
| YoY chg | +8.9% | +14.4% | +9.3% | +11.3% |
| Net profit (₹ Cr) | 49.5 | 41.0 | 41.7 | 55.9 |
| YoY chg | +16.7% | +25.0% | +1.7% | +8.5% |
| Net margin | 13.0% | 11.0% | 11.4% | 13.8% |
| EPS | 5.40 | 4.47 | 4.55 | 0.00 |
Shareholding over time
CSVBy quarter
30 Jun 2026 · promoter 51.00% · public 49.00%2021-032026-06
- Promoter
- Public and others
- Promoter
- 51.00%
- Public
- 49.00%
- Promoter change
- 0.00 pp
- Filed
- 15 Jul 2026
- FII
- 2.77%
- DII
- 0.59%
- Promoter pledged
- 0.00%
Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.
Financials · quarterly statement
CSVStandalone
₹ crore, as filed
| Q2 FY24 | Q3 FY24 | Q4 FY24A | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25A | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26A | Q1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 317.0 | 306.5 | 314.7 | 347.9 | 349.8 | 324.9 | 333.8 | 365.1 | 381.0 | 371.6 | 364.8 | 406.2 | |
| Other income | 4.2 | 4.3 | 4.9 | 5.1 | 6.1 | 5.1 | 6.4 | 6.9 | 7.4 | 7.2 | 7.3 | 8.4 | |
| Total income | 321.2 | 310.7 | 319.6 | 353.0 | 355.9 | 330.1 | 340.1 | 372.0 | 388.4 | 378.8 | 372.1 | 414.6 | |
| Total expenses | 277.5 | 270.1 | 278.1 | 293.4 | 298.9 | 285.5 | 284.8 | 303.7 | 322.1 | 322.4 | 317.1 | 339.8 | |
| └ Finance costs | 0.9 | 0.9 | 1.6 | 1.6 | 1.6 | 1.6 | 1.5 | 1.6 | 1.5 | 1.5 | 1.5 | 1.7 | |
| └ Depreciation | 10.0 | 10.0 | 10.2 | 11.0 | 11.2 | 11.2 | 10.9 | 10.2 | 10.9 | 11.3 | 11.3 | 11.8 | |
| Profit before tax | 43.7 | 40.7 | 41.6 | 59.6 | 56.9 | 44.5 | 55.3 | 68.3 | 66.3 | 56.4 | 55.0 | 74.8 | |
| Tax expense | 10.8 | 11.2 | 10.4 | 14.8 | 14.5 | 11.7 | 14.3 | 16.9 | 16.9 | 15.4 | 13.3 | 19.0 | |
| Net profit | 32.9 | 29.4 | 31.2 | 44.8 | 42.4 | 32.8 | 41.0 | 51.5 | 49.5 | 41.0 | 41.7 | 55.9 | |
| EPS | 3.58 | 3.21 | 3.40 | 4.88 | 4.63 | 3.58 | 4.47 | 5.61 | 5.40 | 4.47 | 4.55 | 6.09 | |
| Net margin | 10.36% | 9.61% | 9.90% | 12.87% | 12.12% | 10.10% | 12.29% | 14.10% | 12.98% | 11.03% | 11.43% | 13.75% | |
| PBT margin | 13.77% | 13.27% | 13.20% | 17.13% | 16.27% | 13.70% | 16.56% | 18.71% | 17.40% | 15.17% | 15.08% | 18.42% | |
| Tax rate | 24.74% | 27.61% | 25.00% | 24.87% | 25.52% | 26.32% | 25.80% | 24.67% | 25.41% | 27.29% | 24.20% | 25.35% |
A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 6 Aug 2026.
INDRAMEDCO at a glance
- INDRAMEDCO closed at ₹335.15 on 6 Oct 2026, +0.36% on the day, -25.0% over one year, 47.7% below its 52-week high of ₹640.85.
- Delivery was 55.9% of traded quantity on 6 Oct 2026, the 50th percentile of its own 1,731 sessions with a reading (20-session average 59.4%, 1-year average 53.6%).
- Market capitalisation is ₹3,072 crore at a trailing P/E of 16.3 (trailing EPS ₹20.51).
- Q1 FY27 results (standalone, filed 6 Aug 2026): revenue ₹406 crore (+11.3% year on year), net profit ₹56 crore (+8.5%); the price moved +5.2% on the first session after.
- Promoters held 51.00% at 30 Jun 2026, unchanged on the previous filing.
- Q2 FY27 results are expected between 30 Oct 2026 and 10 Nov 2026, going by past filing dates — an estimate, not an announcement.
About
CSVMacro sectorHealthcare
Basic industryHospital
ISININE681B01017
SeriesEQ
Listed17 Apr 1997
History from7 May 1997
Sessions7,259
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.
More in Healthcare Services
CSV- APOLLOHOSPApollo Hospitals Enterprise Limited7,914.50-0.88%
- MAXHEALTHMax Healthcare Institute Limited902.50-1.58%
- FORTISFortis Healthcare Limited764.00+0.03%
- YATHARTHYatharth Hospital & Trauma Care Services Limited1,058.80+5.56%
- ASTERDMAster DM Quality Care Limited684.70-0.98%
- MANIPALHOSManipal Health Enterprises Limited690.50+3.52%
- LALPATHLABDr. Lal Path Labs Ltd.1,964.20-0.36%
- ARTEMISMEDArtemis Medicare Services Limited318.35-1.77%
- NEPHROPLUSNephrocare Health Services Limited634.55-0.49%
- GKSLGujarat Kidney And Super Speciality Limited193.62+1.72%
- KIMSKrishna Institute of Medical Sciences Limited693.40-1.71%
- NHNarayana Hrudayalaya Ltd.1,723.80+0.08%
All Healthcare Services stocks on the NSEAll Healthcare stocks on the NSE